Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 26, 2013
Efficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions - a retrospective evaluation (FACTS)Diamant Thaçi, Peter Weisenseel, Sandra Philipp, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 19, 2017
Wirksamkeit und Sicherheit von Fumarsäureestern in Kombination mit Phototherapie bei Patienten mit moderater bis schwerer Plaque-Psoriasis (FAST)Peter Weisenseel, Kristian Reich, Wiebke Griemberg, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 19, 2017
Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate-to-severe plaque psoriasis (FAST)Peter Weisenseel, Kristian Reich, Wiebke Griemberg, et al.
Expert Opinion on Biological Therapy|December 15, 2020
Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO studyAlan Menter, Petr Arenberger, Sigrid Balser, et al.
BMJ Open|September 14, 2021
IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE)Kilian Eyerich, Peter Weisenseel, Andreas Pinter, et al.
The Journal of Dermatology|August 9, 2025
Long-Term Impact of Guselkumab on Skin, Sexuality, and Perceived Stigmatization in Patients With Psoriasis in Routine Clinical Practice: Week 76 Effectiveness and Safety Results From the Prospective German Multicenter G-EPOSS StudySascha Gerdes, Peter Weisenseel, Durdana Groß, et al.
The Journal of Investigative Dermatology|December 13, 2025
Primary keratinocyte model of actinic keratosis reveals UV-induced DNA damage accumulation and persistent IFN signalingLeonardo Elsbroek, Katja Reuschlein, Syrus Karsai, et al.
BMC Complementary and Alternative Medicine|August 14, 2009
Acupuncture in acute herpes zoster pain therapy (ACUZoster) - design and protocol of a randomised controlled trialJohannes Fleckenstein, Sybille Kramer, Philipp Hoffrogge, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 26, 2010
Evidence-based (S3) guideline for the treatment of psoriasis vulgaris - Update: "Therapeutic options" and "Efalizumab"Alexander Nast, Matthias Augustin, Wolf-Henning Boehncke, et al.
JAMA Dermatology|July 31, 2024
Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis: The GUIDE Randomized Clinical TrialKilian Eyerich, Khusru Asadullah, Andreas Pinter, et al.
Pageof 2